1
Orphan Designations
0
FDA Approvals
3
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| alveolar soft part sarcoma | a synthetic drug conjugate comprised of a ligand targeting CD206, a polysaccharide backbone, a valine citrulline linker, and a p-aminobenzyl carbamate self-immolative spacer with the toxin monomethyl auristatin E | Orphan Designation | - |
| soft tissue sarcoma | a synthetic drug conjugate comprised of a ligand targeting CD206, a polysaccharide backbone, a valine citrulline linker, and a p-aminobenzyl carbamate self-immolative spacer with the toxin monomethyl auristatin E | Orphan Designation | - |
| undifferentiated pleomorphic sarcoma | a synthetic drug conjugate comprised of a ligand targeting CD206, a polysaccharide backbone, a valine citrulline linker, and a p-aminobenzyl carbamate self-immolative spacer with the toxin monomethyl auristatin E | Orphan Designation | - |